Effect of ceramic-impregnated "thermoflow" gloves on patients with Raynaud's syndrome: Randomized, placebo-controlled study

Alternative Medicine Review

Volumn 7, Issue 4, 2002, Pages 327-335

  Ko, Gordon D ^a   Berbrayer, David ^a  

^a Canadian Centre for Integrative Medicine   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CERAMICS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; FEMALE; GLOVE; GRIP STRENGTH; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; INFRARED RADIATION; MALE; OUTCOMES RESEARCH; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RAYNAUD PHENOMENON; SCORING SYSTEM; SKIN TEMPERATURE; VISUAL ANALOG SCALE; AGED; DOUBLE BLIND PROCEDURE; HEAT; MIDDLE AGED; PAIN; PROTECTIVE CLOTHING; QUESTIONNAIRE; TEACHING HOSPITAL; TIME; TREATMENT OUTCOME;

ADULT; AGED; CERAMICS; DOUBLE-BLIND METHOD; FEMALE; GLOVES, PROTECTIVE; HEAT; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; QUESTIONNAIRES; RAYNAUD DISEASE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036674518     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Raynaud's phenomenon in a female population: Prevalence and association with other conditions
2. Raynaud's phenomenon: A proposal for classification
3. White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome
4. Raynaud's phenomenon in idiopathic carpal tunnel syndrome
5. Experiments relating to the peripheral mechanism involved in spasmodic arrest of the circulation of the fingers, a variety of Raynaud's syndrome
6. Vascular disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions
7. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood
8. Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of serotonin2 (5-HT2) receptor
9. Increased susceptibility to oxidation of lowdensity lipoproteins isolated from patients with systemic sclerosis
10. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
11. Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon
12. Capillaroscopy in Raynaud's syndrome
13. Sequential dermal microvascular and perivascular changes in the development of scleroderma
14. Induced vasodilation as treatment for Raynaud's disease
15. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon
16. Controlled double blind trial of nisoldipine in the treatment of idiopathic Raynaud's phenomenon
17. Oral ilioprost in Raynaud's phenomenon secondary to systemic sclerosis: A multicentre, placebo-controlled, dose-comparison study
18. Raynaud phenomenon. Treatment with hypnotic and operant technique
19. Induced vasodilation as a home treatment for Raynaud's disease
20. A 1-year follow-up of Raynaud's patients treated with behavioral therapy techniques
21. The behavioral treatment of Raynaud's disease: A review
22. Thermal biofeedback for claudication in diabetes: A literature review and case study
23. Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud's syndrome: A randomised trial
24. Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture
25. Complementary and alternative medicine: Canadian physiatrists' attitudes and behavior
26. Preliminary results of clinical effects of infrared shinguard
27. Cold-induced vasospasm in patients with fibromyalgia and chronic low back pain in comparison to healthy subjects
28. Raynaud's disease: A simple approach to management
29. Development of an upper extremity outcome measure: The DASH (disabilities of the arm, shoulder and hand)
30. The fibromyalgia impact questionnaire: Development and validation
31. The "distal-dorsal difference" as a possible predictor of secondary Raynaud's phenomenon